Angiotensin converting enzyme 2 in the kidney

被引:37
作者
Koitka, A. [1 ]
Cooper, M. E. [1 ]
Thomas, M. C. [1 ]
Tikellis, C. [1 ]
机构
[1] Baker Med Res Inst, Div Diabet Complicat, Melbourne, Vic 8008, Australia
来源
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2008年 / 35卷 / 04期
关键词
angiotensin; 1-7; angiotensin II; angiotensin converting enzyme 2; diabetes; hypertension; renal impairment; rennin-angiotensin system;
D O I
10.1111/j.1440-1681.2008.04889.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Angiotensin converting enzyme 2 (ACE2) is an important homeostatic component of the renin angiotensin system (RAS). ACE2 both degrades the vasoconstrictor, angiotensin II and generates the potent vasodilator peptide, angiotensin 1-7. These actions counterbalance those of ACE. 2. ACE2 is highly expressed in the healthy kidney, particularly in the proximal tubules, where it colocalizes with ACE and angiotensin receptors. 3. Kidney disease and subtotal nephrectomy is associated with a reduction in renal ACE2 expression, possibly facilitating the damaging effects of angiotensin II in the failing kidney. Acquired or genetic ACE2 deficiency also appears to exacerbate renal damage and albuminuria in experimental models, supporting this hypothesis. 4. ACE2 also has an important role in blood pressure control. Many models of hypertension are associated with reduced ACE2 expression. Although ACE2 KO animals are normotensive, in states associated with activation of the RAS, ACE2 overexpression improves blood pressure control and reduces angiotensin responsiveness.
引用
收藏
页码:420 / 425
页数:6
相关论文
共 61 条
  • [1] RENAL RENIN-ANGIOTENSIN SYSTEM IN DIABETES - FUNCTIONAL, IMMUNOHISTOCHEMICAL, AND MOLECULAR BIOLOGICAL CORRELATIONS
    ANDERSON, S
    JUNG, FF
    INGELFINGER, JR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (04): : F477 - F486
  • [2] SHORT AND LONG-TERM EFFECTS OF ANTIHYPERTENSIVE THERAPY IN THE DIABETIC RAT
    ANDERSON, S
    RENNKE, HG
    GARCIA, DL
    BRENNER, BM
    [J]. KIDNEY INTERNATIONAL, 1989, 36 (04) : 526 - 536
  • [3] No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension
    Benjafield, AV
    Wang, WYS
    Morris, BJ
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (07) : 624 - 628
  • [4] Angiotensinogen modulates renal vasculature growth
    Brand, Marcus
    Lamande, Noel
    Sigmund, Curt D.
    Larger, Etienne
    Corvol, Pierre
    Gasc, Jean-Marie
    [J]. HYPERTENSION, 2006, 47 (06) : 1067 - 1074
  • [5] Brosnihan KB, 2003, HYPERTENSION, V42, P749, DOI 10.1161/01.HYP.0000085220.53285.11
  • [6] Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide
    Brosnihan, KB
    Li, P
    Ferrario, CM
    [J]. HYPERTENSION, 1996, 27 (03) : 523 - 528
  • [7] Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury
    Cao, ZM
    Bonnet, F
    Candido, R
    Nesteroff, SP
    Burns, WC
    Kawachi, H
    Shimizu, F
    Carey, RM
    De Gasparo, M
    Cooper, ME
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07): : 1773 - 1787
  • [8] Metabolism of angiotension-(1-7) by angiotensin-converting enzyme
    Chappell, MC
    Pirro, NT
    Sykes, A
    Ferrario, CM
    [J]. HYPERTENSION, 1998, 31 (01) : 362 - 367
  • [9] Differential actions of angiotensin-(1-7) in the kidney
    Chappell, MC
    Diz, DI
    Yunis, C
    Ferrario, CM
    [J]. KIDNEY INTERNATIONAL, 1998, 54 : S3 - S6
  • [10] Functional conservation of the active sites of human and Drosophila angiotensin I-converting enzyme
    Coates, D
    Isaac, RE
    Cotton, J
    Siviter, R
    Williams, TA
    Shirras, A
    Corvol, P
    Dive, V
    [J]. BIOCHEMISTRY, 2000, 39 (30) : 8963 - 8969